Anadil Javaid Clinical Oncology Society of Australia Annual Scientific Meeting 2022

Abstracts this author is presenting:

• CDK4/6 Inhibitors (CKD4/6i) in advanced Hormone-Receptor-Positive (HR+) HER2-Negative (HER2-) breast cancer: prescribing practices and outcomes in a real-world, Australian cohort — Poster session 1